Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Understanding glycans and enzymes that alter them is key to controlling hair growth.

Immune cells affect hair growth and could lead to new hair loss treatments.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.